509 related articles for article (PubMed ID: 20368733)
1. Mesenchymal stem cells: a new strategy for immunosuppression and tissue repair.
Shi Y; Hu G; Su J; Li W; Chen Q; Shou P; Xu C; Chen X; Huang Y; Zhu Z; Huang X; Han X; Xie N; Ren G
Cell Res; 2010 May; 20(5):510-8. PubMed ID: 20368733
[TBL] [Abstract][Full Text] [Related]
2. Requirement of IFN-gamma-mediated indoleamine 2,3-dioxygenase expression in the modulation of lymphocyte proliferation by human adipose-derived stem cells.
DelaRosa O; Lombardo E; Beraza A; Mancheño-Corvo P; Ramirez C; Menta R; Rico L; Camarillo E; García L; Abad JL; Trigueros C; Delgado M; Büscher D
Tissue Eng Part A; 2009 Oct; 15(10):2795-806. PubMed ID: 19231921
[TBL] [Abstract][Full Text] [Related]
3. Comparison of immunomodulatory properties of mesenchymal stem cells derived from adult human tissues.
Yoo KH; Jang IK; Lee MW; Kim HE; Yang MS; Eom Y; Lee JE; Kim YJ; Yang SK; Jung HL; Sung KW; Kim CW; Koo HH
Cell Immunol; 2009; 259(2):150-6. PubMed ID: 19608159
[TBL] [Abstract][Full Text] [Related]
4. IFN-gamma and TNF-alpha differentially regulate immunomodulation by murine mesenchymal stem cells.
English K; Barry FP; Field-Corbett CP; Mahon BP
Immunol Lett; 2007 Jun; 110(2):91-100. PubMed ID: 17507101
[TBL] [Abstract][Full Text] [Related]
5. Although pig allogeneic mesenchymal stem cells are not immunogenic in vitro, intracardiac injection elicits an immune response in vivo.
Poncelet AJ; Vercruysse J; Saliez A; Gianello P
Transplantation; 2007 Mar; 83(6):783-90. PubMed ID: 17414713
[TBL] [Abstract][Full Text] [Related]
6. Immunosuppressive effects of mesenchymal stem cells: involvement of HLA-G.
Nasef A; Mathieu N; Chapel A; Frick J; François S; Mazurier C; Boutarfa A; Bouchet S; Gorin NC; Thierry D; Fouillard L
Transplantation; 2007 Jul; 84(2):231-7. PubMed ID: 17667815
[TBL] [Abstract][Full Text] [Related]
7. Immunosuppressive mechanisms of embryonic stem cells and mesenchymal stem cells in alloimmune response.
Han KH; Ro H; Hong JH; Lee EM; Cho B; Yeom HJ; Kim MG; Oh KH; Ahn C; Yang J
Transpl Immunol; 2011 Jul; 25(1):7-15. PubMed ID: 21635949
[TBL] [Abstract][Full Text] [Related]
8. Allogeneic mesenchymal stem cell and mesenchymal stem cell-differentiated chondrocyte suppress the responses of type II collagen-reactive T cells in rheumatoid arthritis.
Zheng ZH; Li XY; Ding J; Jia JF; Zhu P
Rheumatology (Oxford); 2008 Jan; 47(1):22-30. PubMed ID: 18077486
[TBL] [Abstract][Full Text] [Related]
9. A critical role of IFNgamma in priming MSC-mediated suppression of T cell proliferation through up-regulation of B7-H1.
Sheng H; Wang Y; Jin Y; Zhang Q; Zhang Y; Wang L; Shen B; Yin S; Liu W; Cui L; Li N
Cell Res; 2008 Aug; 18(8):846-57. PubMed ID: 18607390
[TBL] [Abstract][Full Text] [Related]
10. Leukemia inhibitory factor: Role in human mesenchymal stem cells mediated immunosuppression.
Nasef A; Mazurier C; Bouchet S; François S; Chapel A; Thierry D; Gorin NC; Fouillard L
Cell Immunol; 2008; 253(1-2):16-22. PubMed ID: 18639869
[TBL] [Abstract][Full Text] [Related]
11. Mesenchymal stem cells: a new strategy for immunosuppression?
Uccelli A; Pistoia V; Moretta L
Trends Immunol; 2007 May; 28(5):219-26. PubMed ID: 17400510
[TBL] [Abstract][Full Text] [Related]
12. Mesenchymal stromal cells.
Bernardo ME; Locatelli F; Fibbe WE
Ann N Y Acad Sci; 2009 Sep; 1176():101-17. PubMed ID: 19796238
[TBL] [Abstract][Full Text] [Related]
13. Mesenchymal stromal cells lose their immunosuppressive potential after allotransplantation.
Prigozhina TB; Khitrin S; Elkin G; Eizik O; Morecki S; Slavin S
Exp Hematol; 2008 Oct; 36(10):1370-6. PubMed ID: 18619727
[TBL] [Abstract][Full Text] [Related]
14. Enhanced Immunosuppression of T Cells by Sustained Presentation of Bioactive Interferon-γ Within Three-Dimensional Mesenchymal Stem Cell Constructs.
Zimmermann JA; Hettiaratchi MH; McDevitt TC
Stem Cells Transl Med; 2017 Jan; 6(1):223-237. PubMed ID: 28170190
[TBL] [Abstract][Full Text] [Related]
15. Preconditioning mesenchymal stem cells with transforming growth factor-alpha improves mesenchymal stem cell-mediated cardioprotection.
Herrmann JL; Wang Y; Abarbanell AM; Weil BR; Tan J; Meldrum DR
Shock; 2010 Jan; 33(1):24-30. PubMed ID: 19996917
[TBL] [Abstract][Full Text] [Related]
16. Mesenchymal stem cells attenuate renal fibrosis through immune modulation and remodeling properties in a rat remnant kidney model.
Semedo P; Correa-Costa M; Antonio Cenedeze M; Maria Avancini Costa Malheiros D; Antonia dos Reis M; Shimizu MH; Seguro AC; Pacheco-Silva A; Saraiva Camara NO
Stem Cells; 2009 Dec; 27(12):3063-73. PubMed ID: 19750536
[TBL] [Abstract][Full Text] [Related]
17. Species variation in the mechanisms of mesenchymal stem cell-mediated immunosuppression.
Ren G; Su J; Zhang L; Zhao X; Ling W; L'huillie A; Zhang J; Lu Y; Roberts AI; Ji W; Zhang H; Rabson AB; Shi Y
Stem Cells; 2009 Aug; 27(8):1954-62. PubMed ID: 19544427
[TBL] [Abstract][Full Text] [Related]
18. Immunosuppression by placental indoleamine 2,3-dioxygenase: a role for mesenchymal stem cells.
Jones BJ; Brooke G; Atkinson K; McTaggart SJ
Placenta; 2007; 28(11-12):1174-81. PubMed ID: 17714779
[TBL] [Abstract][Full Text] [Related]
19. Human umbilical cord mesenchymal stem cells hUC-MSCs exert immunosuppressive activities through a PGE2-dependent mechanism.
Chen K; Wang D; Du WT; Han ZB; Ren H; Chi Y; Yang SG; Zhu D; Bayard F; Han ZC
Clin Immunol; 2010 Jun; 135(3):448-58. PubMed ID: 20207200
[TBL] [Abstract][Full Text] [Related]
20. Immune regulation by mesenchymal stem cells: two sides to the coin.
Stagg J
Tissue Antigens; 2007 Jan; 69(1):1-9. PubMed ID: 17212702
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
